Fig. 3From: Safety studies and viral shedding of intramuscular administration of oncolytic vaccinia virus TG6002 in healthy beagle dogsWeight (a) and temperature (b) of dogs after three intramuscular injections of TG6002. No significant change in the weight and temperature of dogs was noticed after repeated intramuscular injections of TG6002 at 5 × 107 PFU/kg. Arrows indicate TG6002 administrations. Dotted lines represent the reference intervalBack to article page